New affiliated members ADITEC aims to produce new knowledge for the next generation of new human vaccines. This goal requires a multidisciplinary approach where diverse…
Partners of the ADITEC consortium are presenting the third course on adjuvants and vaccine formulation. Dates: 9-13 February 2015 Location: Vaccine Formulation Laboratory at University…
Support for Vaccine Development Deadline: 30 May 2014 5:00 p.m. CET Anticipated Decision Date 30 June 2014 Please forward this message to anyone who could…
Happy New Year The ADITEC project team wishes all partners, collaborators and those who are interested in our work, a very Happy New year! In…
ADITEC’s second year progress The high impact project Advanced Immunization Technologies (ADITEC) started as an ambitious €30 million EU project to boost vaccine research. During…
The Institute for Biomedical Aging (IBA) was founded in 1992 as an institute of the Austrian Academy of Sciences and joined the University of Innsbruck…
Leiden University Medical Center (LUMC) is a medical centre of excellence that provides clinical inpatient and outpatient care, modern education, and innovative basic, translational and…
Support for Vaccine Development Deadline: 30 May 2013 5:00 p.m. CEST Anticipated Decision Date 30 June 2013 Please forward this message to anyone who could…
ADITEC’s first year progress The high impact project Advanced Immunization Technologies (ADITEC) started as an ambitious €30 million EU project to boost vaccine research. During…
Adjuvanted trivalent influenza vaccine: a randomised controlled trial to determine the kinetics of the functional genomic response in young children. In the 2012 influenza season,…